 | Up a level |
Chatenet, D; Cescato, R; Waser, B; Rivier, J; Reubi, JC (2011). Synthesis and characterization of DOTA-coupled dimeric Y1 receptors antagonists for breast cancer targeting. In: Lebl, M (ed.) Proceeding of the 22nd American Peptide Symposium. American Peptide Society
Rivier, J; Gulyas, J; Erchegyi, J; Koerber, SC; Grace, C; Riek, R; DiGruccio, M; Perrin, M; Rivier, C; Eltschinger, V; Waser, B; Cescato, R; Reubi, J.C.; Vale, W (2006). Guiding principles applied in the design of GPCR-selective hypothalamic hormone agonists and antagonists. In: Insights into Receptor Function and New Drug Development Targets (pp. 117-138). Heidelberg: Springer Verlag 10.1007/3-540-34447-0_8
